drugset / Trial / NCT00347373
Effect of Conjugated Linoleic Acid Supplement on Body Composition
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve weeks. Changes in body composition, weight, and clinical laboratory values are compared between the three groups.
Timeline
- Start
- 2004-08
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conjugated Linoleic Acid | Unknown | 3.2 g | — |
| Subject | Conjugated Linoleic Acid | Unknown | 6.4 g | — |